Mescaline is under clinical development by Mind Medicine MindMed and currently in Phase I for Unspecified Psychiatric Disorders.

Mebufotenin is under clinical development by GH Research and currently in Phase I for Unspecified Psychiatric Disorders.

Once sidelined in the 1970s, psychedelic substances—ranging from esketamine (a ketamine derivative) and psilocybin (the ...

Renowned scientist Dr. Cathy Barr reveals groundbreaking insights into the genetic underpinnings of childhood psychiatric and ...

Diagnoses of PTSD and anxiety disorders nearly doubled between 2019 and 2023, according to a new Defense Health Agency report ...

A study of individuals with various psychiatric disorders found that gut microbiota composition is associated with changes in ...

Growing brain research reveals the habenula's outsize impact on our health, from mood and anxiety to addiction and sleep.

In this cohort study, prenatal exposure to glucocorticoids was associated with higher risk of some mental disorders. These data support continued caution in the use of glucocorticoids in pregnant ...

Most people with mental illness suffer from bipolar disorder, depression, anxiety and schizophrenia, among others ...

China's National Health Commission said that it would address gaps in its mental health services from 2025 to 2027 as ...